Qube Research & Technologies (QRT)’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.02M | Buy |
121,822
+4,602
| +4% | +$152K | ﹤0.01% | 1346 |
|
2025
Q1 | $4.71M | Buy |
117,220
+53,690
| +85% | +$2.16M | 0.01% | 1236 |
|
2024
Q4 | $2.99M | Buy |
+63,530
| New | +$2.99M | ﹤0.01% | 1356 |
|
2024
Q3 | – | Sell |
-1,466
| Closed | -$79.4K | – | 2936 |
|
2024
Q2 | $79.4K | Sell |
1,466
-28,562
| -95% | -$1.55M | ﹤0.01% | 2282 |
|
2024
Q1 | $2.11M | Sell |
30,028
-320,507
| -91% | -$22.5M | ﹤0.01% | 1469 |
|
2023
Q4 | $29.3M | Buy |
350,535
+340,827
| +3,511% | +$28.5M | 0.06% | 346 |
|
2023
Q3 | $286K | Sell |
9,708
-85,848
| -90% | -$2.53M | ﹤0.01% | 1875 |
|
2023
Q2 | $3.12M | Sell |
95,556
-6,942
| -7% | -$226K | 0.01% | 799 |
|
2023
Q1 | $3.61M | Buy |
+102,498
| New | +$3.61M | 0.02% | 707 |
|
2021
Q4 | – | Sell |
-12,374
| Closed | -$442K | – | 2601 |
|
2021
Q3 | $442K | Buy |
+12,374
| New | +$442K | 0.01% | 1274 |
|
2020
Q4 | – | Sell |
-13,748
| Closed | -$298K | – | 1874 |
|
2020
Q3 | $298K | Sell |
13,748
-10,091
| -42% | -$219K | ﹤0.01% | 1246 |
|
2020
Q2 | $562K | Buy |
+23,839
| New | +$562K | 0.01% | 1066 |
|